Doxorubicin Hydrochloride liposome
- Product NDC
- 59676-966
- 11-digit product format
- 596760966
- Labeler code
- 59676
- Product ID
- 59676-966_2100bf6a-67f3-11e9-9dee-13020199106d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxorubicin hydrochloride
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INTRAVENOUS
- Labeler
- Janssen Products, LP
- Application
- NDA050718
- Marketing category
- NDA
- Marketing start
- 2017-06-26
- Marketing end
- 2020-10-31
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record